CEO Initiative Aims To Reduce Development Time For Alzheimer’s Drugs
This article was originally published in The Pink Sheet Daily
Executive Summary
A group of CEOs from Big Pharma, biotech and finance companies have joined forces with philanthropists and health care policy makers to call for a global action plan against Alzheimer's disease.